Thomas Gasser

88.8k total citations · 10 hit papers
544 papers, 35.4k citations indexed

About

Thomas Gasser is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Thomas Gasser has authored 544 papers receiving a total of 35.4k indexed citations (citations by other indexed papers that have themselves been cited), including 329 papers in Neurology, 136 papers in Cellular and Molecular Neuroscience and 93 papers in Molecular Biology. Recurrent topics in Thomas Gasser's work include Parkinson's Disease Mechanisms and Treatments (246 papers), Neurological disorders and treatments (129 papers) and Neurological diseases and metabolism (67 papers). Thomas Gasser is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (246 papers), Neurological disorders and treatments (129 papers) and Neurological diseases and metabolism (67 papers). Thomas Gasser collaborates with scholars based in Germany, United States and Switzerland. Thomas Gasser's co-authors include Daniela Berg, Ronald B. Postuma, Glenda M. Halliday, Irene Litvan, Werner Poewe, José Á. Obeso, Günther Deuschl, Anthony E. Lang, Kenneth Marek and Christopher G. Goetz and has published in prestigious journals such as Science, The Lancet and Nucleic Acids Research.

In The Last Decade

Thomas Gasser

532 papers receiving 34.6k citations

Hit Papers

MDS clinical diagnostic c... 1998 2026 2007 2016 2015 2015 2009 2011 2011 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. MDS clinical diagnostic criteria for Parkinson's disease
    2015 4.8k citations Ronald B. Postuma, Daniela Berg et al. Movement Disorders profile →
  2. MDS research criteria for prodromal Parkinson's disease
    2015 876 citations Daniela Berg, Ronald B. Postuma et al. Movement Disorders profile →
  3. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
    2009 698 citations Thomas Gasser, Glenda M. Halliday et al. profile →
  4. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies
    2011 660 citations Claudia Schulte, John Hardy et al. profile →
  5. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial
    2011 599 citations Thomas Gasser et al. profile →
  6. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
    2012 560 citations Thomas Gasser et al. profile →
  7. The phenotypic spectrum of CADASIL: Clinical findings in 102 cases
    1998 502 citations Thomas Gasser et al. profile →
  8. Update of the MDS research criteria for prodromal Parkinson's disease
    2019 465 citations Daniela Berg, Thomas Gasser et al. Movement Disorders profile →
  9. iPSC-derived neurons from GBA1-associated Parkinson’s disease patients show autophagic defects and impaired calcium homeostasis
    2014 406 citations David C. Schöndorf, Benjamin Schmid et al. Nature Communications profile →
  10. CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease
    2024 34 citations Kathrin Brockmann, Stefanie Lerche et al. npj Parkinson s Disease profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thomas Gasser 21.1k 8.8k 7.8k 5.6k 4.9k 544 35.4k
Daniela Berg 19.8k 0.9× 6.8k 0.8× 5.7k 0.7× 4.6k 0.8× 4.2k 0.9× 533 29.2k
Jörg B. Schulz 8.1k 0.4× 7.6k 0.9× 9.4k 1.2× 3.8k 0.7× 3.2k 0.7× 472 25.5k
Nobutaka Hattori 19.7k 0.9× 10.6k 1.2× 15.5k 2.0× 7.5k 1.3× 5.8k 1.2× 1.1k 42.6k
K. A. Jellinger 21.7k 1.0× 11.2k 1.3× 9.1k 1.2× 13.4k 2.4× 9.7k 2.0× 1.0k 48.6k
John H. Zhang 14.0k 0.7× 3.5k 0.4× 11.8k 1.5× 3.2k 0.6× 8.1k 1.7× 1.1k 42.3k
Satoshi Minoshima 7.6k 0.4× 5.3k 0.6× 9.3k 1.2× 8.8k 1.6× 3.9k 0.8× 441 35.6k
Ulrich Dirnagl 5.4k 0.3× 5.6k 0.6× 8.9k 1.1× 4.2k 0.7× 9.5k 1.9× 388 35.1k
John C. van Swieten 10.0k 0.5× 3.1k 0.4× 4.4k 0.6× 7.1k 1.3× 4.2k 0.9× 268 23.7k
Massimo Filippi 24.3k 1.2× 4.4k 0.5× 8.5k 1.1× 4.6k 0.8× 7.9k 1.6× 1.5k 76.9k
Matthew P. Frosch 8.3k 0.4× 6.4k 0.7× 9.4k 1.2× 16.8k 3.0× 6.5k 1.3× 299 32.3k

Countries citing papers authored by Thomas Gasser

Since Specialization
Citations

This map shows the geographic impact of Thomas Gasser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Gasser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Gasser more than expected).

Fields of papers citing papers by Thomas Gasser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Gasser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Gasser. The network helps show where Thomas Gasser may publish in the future.

Co-authorship network of co-authors of Thomas Gasser

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Gasser. A scholar is included among the top collaborators of Thomas Gasser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Gasser. Thomas Gasser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zimmermann, Milan, Meike Jakobi, Benjamin Röeben, et al.. (2025). Elevated cerebrospinal fluid levels of SERPIN E1 in participants with lewy body diseases. npj Parkinson s Disease. 11(1). 166–166.
2.
Brockmann, Kathrin, Stefanie Lerche, Simone Baiardi, et al.. (2024). CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease. npj Parkinson s Disease. 10(1). 24–24. 34 indexed citations breakdown →
3.
Röeben, Benjamin, Inga Liepelt‐Scarfone, Stefanie Lerche, et al.. (2024). Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers. npj Parkinson s Disease. 10(1). 88–88. 5 indexed citations
4.
Rossi, Marcello, Thomas Henle, Thomas Gasser, et al.. (2023). Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders. Acta Neuropathologica Communications. 11(1). 162–162. 26 indexed citations
5.
Zafar, Saima, Neelam Younas, Mohsin Shafiq, et al.. (2022). SWATH Mass Spectrometry-Based CSF Proteome Profile of GBA-Linked Parkinson’s Disease Patients. International Journal of Molecular Sciences. 23(22). 14166–14166. 4 indexed citations
6.
Brunet, Theresa, Riccardo Berutti, Veronika Dill, et al.. (2022). Clonal hematopoiesis as a pitfall in germline variant interpretation in the context of Mendelian disorders. Human Molecular Genetics. 31(14). 2386–2395. 4 indexed citations
7.
Becker, Sara, Kathrin Brockmann, Thomas Gasser, et al.. (2022). Evaluation of the Dementia Apraxia Test in Parkinson’s Disease Patients. Dementia and Geriatric Cognitive Disorders. 51(3). 271–278. 2 indexed citations
8.
Becker, Sara, Kathrin Brockmann, Thomas Gasser, et al.. (2022). Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease. Neurology. 99(23). e2548–e2560. 13 indexed citations
9.
Becker, Sara, Claire Pauly, Michael Lawton, et al.. (2021). Quantifying activities of daily living impairment in Parkinson’s disease using the Functional Activities Questionnaire. Neurological Sciences. 43(2). 1047–1054. 3 indexed citations
10.
Lerche, Stefanie, Simon Sjödin, Ann Brinkmalm, et al.. (2021). CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB. Movement Disorders. 36(11). 2595–2604. 16 indexed citations
11.
Oliveira, Luís M. A., Thomas Gasser, Robert H. Edwards, et al.. (2021). Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease. npj Parkinson s Disease. 7(1). 65–65. 96 indexed citations
12.
Panagiotakopoulou, Vasiliki, Dina Ivanyuk, Silvia De Cicco, et al.. (2020). Interferon-γ signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells. Nature Communications. 11(1). 5163–5163. 87 indexed citations
13.
Lerche, Stefanie, Isabel Wurster, Milan Zimmermann, et al.. (2020). CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories. Movement Disorders. 35(7). 1138–1144. 35 indexed citations
14.
Lerche, Stefanie, Isabel Wurster, Gerrit Machetanz, et al.. (2018). Parkinson’s disease: evolution of cognitive impairment and CSF Aβ1–42 profiles in a prospective longitudinal study. Journal of Neurology Neurosurgery & Psychiatry. 90(2). 165–170. 17 indexed citations
15.
Singleton, Andrew, John Hardy, & Thomas Gasser. (2017). The Birth of the Modern Era of Parkinson's Disease Genetics. UCL Discovery (University College London). 15 indexed citations
16.
Rasmussen, Mikkel A., Christian Clausen, Ulrike A. Mau‐Holzmann, et al.. (2016). Generation of induced pluripotent stem cells derived from a 77-year-old healthy woman as control for age related diseases. Stem Cell Research. 17(3). 550–552. 2 indexed citations
17.
Berg, Daniela, Ronald B. Postuma, Bastiaan R. Bloem, et al.. (2014). Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Movement Disorders. 29(4). 454–462. 341 indexed citations
18.
Theysohn, Nina, Kyung‐Eun Choi, Elke R. Gizewski, et al.. (2014). Acupuncture-Related Modulation of Pain-Associated Brain Networks During Electrical Pain Stimulation: A Functional Magnetic Resonance Imaging Study. The Journal of Alternative and Complementary Medicine. 20(12). 893–900. 19 indexed citations
19.
Gasser, Thomas, et al.. (2001). [A comparison of cholinesterase inhibitors and ginkgo extract in treatment of Alzheimer dementia].. PubMed. 119(3-4). 135–8. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Berg Breakdown of academic impact, for papers by Jörg B. Schulz Breakdown of academic impact, for papers by Nobutaka Hattori Breakdown of academic impact, for papers by K. A. Jellinger Breakdown of academic impact, for papers by John H. Zhang Breakdown of academic impact, for papers by Satoshi Minoshima Breakdown of academic impact, for papers by Ulrich Dirnagl Breakdown of academic impact, for papers by John C. van Swieten Breakdown of academic impact, for papers by Massimo Filippi Breakdown of academic impact, for papers by Matthew P. Frosch
Rankless by CCL
2026